We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRWD:NASDAQCrowdStrike Holdings, Inc. Analysis

Data as of 2026-09-01 - not real-time

$215.07

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $215.07, CrowdStrike Holdings, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 12.5% over the past 30 days. RSI sits at 54.5, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $181.24 and resistance around $233.88.
Multiples put this in overvalued territory: 4301.4 times earnings against the sector's 35.3. Consensus targets land 6.6% above where the shares trade now. Revenue is growing at 25.8% on a 0.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 76.1%, a beta of 1.62 and a maximum drawdown of 37.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 1/10 conviction over the longer horizon.

Top Market Events

CrowdStrike Holdings CRWD ended the recent trading session at $225.TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the ‘TCW Concentrated...AUSTIN, Texas, August 26, 2026--CrowdStrike Holdings, Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 141.33
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 4301.4 versus sector average of 35.3
  • Trading above the 200-day average of 141.33

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 4301.4 versus sector average of 35.3
  • Analyst targets imply +6.6% versus the current price
  • Revenue growth of +25.8%

Key Metrics & Analysis

Financial Health

Revenue Growth25.80%
Profit Margin0.83%
P/E Ratio4301.4
ROE1.46%
ROA-0.78%
Debt/Equity15.96
P/B Ratio47.3
Op. Cash Flow$2.0B
Free Cash Flow$2.0B
Industry P/E35.3

Technical Analysis

TrendBullish
RSI54.5
Support$181.24
Resistance$233.88
MA 20$210.57
MA 50$198.35
MA 200$141.33
MACDBullish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Fair Value$71.54
Target Price$229.31
Upside/Downside6.62%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.62
Volatility76.09%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.